(16 days)
No
The document describes standard ECG analysis features and mentions "software analysis options" but does not use terms like AI, ML, deep learning, or neural networks. The analysis described appears to be based on traditional signal processing and pattern recognition techniques common in ECG interpretation systems of that era.
No.
The document states that the device is intended to "acquire, analyze, display, and record electrocardiographic information," indicating it is a diagnostic tool, not a therapeutic one.
Yes
The "Intended Use / Indications for Use" states that the device is intended to "acquire, analyze, display, and record electrocardiographic information," which is a diagnostic function.
No
The device description explicitly states it has "two basic components: the processing unit and the patient acquisition module," and mentions a "modular patient data acquisition device called the CAM14," indicating it includes hardware components beyond just software.
Based on the provided text, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the body (like blood, urine, tissue). The MAC 5000 ECG Analysis System acquires, analyzes, displays, and records electrocardiographic information directly from the patient's body using surface electrodes. It's measuring electrical signals generated by the heart, not analyzing a biological sample.
- The intended use and device description clearly focus on acquiring and analyzing electrical signals from the heart. There is no mention of analyzing biological specimens.
Therefore, the MAC 5000 ECG Analysis System falls under the category of a medical device that performs physiological measurements, not an IVD.
N/A
Intended Use / Indications for Use
The MAC 5000 ECG Analysis System is intended to acquire, analyze, display, and record electrocardiographic information for adult and pediatric populations. Basic Systems deliver 3, 6, 12, or 15 lead ECG's, 12 lead interpretive analysis, vector loops, and can be upgraded to provide software analysis options such as high resolution signal averaging of QRS and P wave portions of the electrocardiogram. Transmission and reception of ECG data to and from a central ECG cardiovascular information system is optional. The MAC 5000 is intended to be used under the direct supervision of a licensed medical professional in a hospital or medical professional's facility.
Product codes
74MHX, 74DSI, 74DQK, 74FYW, 74DXH, DPS
Device Description
The MAC 5000 ECG Analysis System is designed to acquire, analyze, display, and record ECG signals from surface ECG electrodes. The system is comprised of two basic components: the processing unit and the patient acquisition module. Models provide rechargeable battery operation and/or optional trolley for transporting the equipment.
The MAC 5000 can deliver 3, 6, 12, or 15 lead ECG's, 12 lead interpretive analysis, vector loops, and can be upgraded to provide software analysis options such as high resolution signal averaging of QRS and P wave portions of the electrocardiogram. Transmission and reception of ECG data to and from a central ECG cardiovascular information system is optional.
The MAC 5000 system acquires ECG data using a modular patient data acquisition device called the CAM14 (K991735). By placing the data acquisition device closer to the patient, signal fidelity is improved and noise is reduced. MAC 5000 delivers 12 or 15 lead ECG's on fullsize reports with alphanumeric keyboard for patient demographics and other data entry, a full size VGA graphics and waveform display, integrated thermal writer and removable data storage.
Additionally, the MAC 5000 utilizes battery power for customer convenience and can transmit and receive ECGs to and from a central ECG cardiovascular information system via optional communication links. The system is intended as a mobile device but the main unit can be separated from the trolley and used as a desktop unit.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult and pediatric populations
Intended User / Care Setting
Licensed medical professional in a hospital or medical professional's facility.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The MAC 5000 ECG Analysis System complies with the voluntary standards as detailed in Section 9 of this submission. The following activities were conducted for the development of the system:
- Risk Analysis.
- Technical Reviews.
- Design Reviews.
- Code Inspections.
- Unit level Testing (module verification).
- Integration Testing (system verification).
- Final Acceptance Testing (validation).
- Performance Testing.
- Safety Testing.
The results of these measurements demonstrated that the MAC 5000 system is as safe, as effective, and performs as well as the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2340 Electrocardiograph.
(a)
Identification. An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.(b)
Classification. Class II (performance standards).
0
K042177
f. 1/2
AUG 27 2004
510(k) Summary of Safety and Effectiveness
August 6, 2004 Date:
GE Medical Systems Information Technologies Submitter: 8200 West Tower Avenue Milwaukee, WI 53223 USA
Lisa M. Baumhardt Contact Person: Regulatory Affairs Specialist GE Medical Systems Information Technologies Phone: 262-293-1699 Fax: 262-293-1460
MAC 5000 ECG Analysis System Trade Name: Device:
Electrocardiograph Common/Usual Name:
Classification Names:
| 21 CFR 870.1025 Monitor, Physiological Patient (with Arrhythmia Detection or Alarms) | 74MHX |
|---|---|
| 21 CFR 870.1025 Detector and Alarm, Arrhythmia | 74DSI |
| 21 CFR 870.1425 Programmable Diagnostic Computer | 74DQK |
| 21 CFR 870.2340 Electrocardiograph | 74FYW |
| 21 CFR 870.2920 Transmitters and Receivers, Electrocardiograph, Telephone | 74DXH |
K033492 MAC 5000 ECG Analysis System Predicate Device:
The MAC 5000 ECG Analysis System is designed to acquire, analyze, Device Description: display, and record ECG signals from surface ECG electrodes. The display, and two basic components: the processing unit and the patient acquisition module. Models provide rechargeable battery operation and/or optional trolley for transporting the equipment.
The MAC 5000 can deliver 3, 6, 12, or 15 lead ECG's, 12 lead interpretive analysis, vector loops, and can be upgraded to provide software analysis options such as high resolution signal averaging of QRS and P wave portions of the electrocardiogram. Transmission and reception of ECG data to and from a central ECG cardiovascular information system is optional.
The MAC 5000 system acquires ECG data using a modular patient data acquisition device called the CAM14 (K991735). By placing the data acquisition device closer to the patient, signal fidelity is improved and noise is reduced. MAC 5000 delivers 12 or 15 lead ECG's on fullsize reports with alphanumeric keyboard for patient demographics and other data entry, a full size VGA graphics and waveform display, integrated thermal writer and removable data storage.
Additionally, the MAC 5000 utilizes battery power for customer convenience and can transmit and receive ECGs to and from a central ECG cardiovascular information system via optional communication links. The system is intended as a mobile device but the main unit can be separated from the trolley and used as a desktop unit.
1
K04277
2/2
-
The MAC 5000 ECG Analysis System is intended to acquire, analyze, Intended Use: The MAC 3000 EOO Analysis information adult and pediation ulsplay, and record clock. Sie and all gr 3, 6, 12, or 15 lead ECG's, 12 lead populations. Dasio systems don'ts of can be upgraded to provide merpretive analysis, vootor loops, and resolution signal averaging of Sollware analysis options of the electrocardiogram. Transmission and QRS and I wave portions of and from a central ECG cardiovascular information system is optional.
The MAC 5000 is intended to be used under the direct supervision of a The MAC 5000 is michaou to be be as a loss and a hospital or medical professional's facility. -
The MAC 5000 ECG Analysis System employs the same functional Technology: technology as the predicate devices.
-
The MAC 5000 ECG Analysis System complies with the voluntary Test Summary: standards as detailed in Section 9 of this submission. The following Standards as detailed in Soction of the development of the system:
- Risk Analysis .
- Technical Reviews .
- Design Reviews .
- Code Inspections .
- Unit level Testing (module verification) .
- Integration Testing (system verification) .
- Final Acceptance Testing (validation) .
- Performance Testing .
- Safety Testing .
- The results of these measurements demonstrated that the MAC 5000 Conclusion: The Tosalto of thosem is as safe, as effective, and performs as well as the predicate devices.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle with three human profiles incorporated into its design. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
JAN 2 2 2008
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
GE Medical Systems Information Technologies c/o Ms. Margaret Mucha Regulatory Affairs Leader 9900 Innovation Drive Wauwatosa, WI 53226
Re: K042177
Trade/Device Name: MAC 5500 Resting ECG Regulation Number: 21 CFR 870.2340 Regulation Name: Electrocardiograph Regulatory Class: II (two) Product Code: DPS Dated: August 6, 2004 Received: August 11, 2004
Dear Ms. Mucha:
This letter corrects our substantially equivalent letter of August 27, 2004.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Margaret Mucha
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours, .
Blommerfor fr
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
长042177
Page 1 of 1
510(k) Number (if known):
MAC 5000 ECG Analysis System
Device Name:
Indications For Use:
The MAC 5000 ECG Analysis System is intended to acquire, analyze, display, and record
eliver The MAC 5000 ECG Analysis System is intended to acquilot intaly Basic Systems deliver
electrocardiographic information adult and pediations and can be electrocardiographic information addit and peakalise, vector loops, and can be
3, 6, 12, or 15 lead ECG's, 12 lead interpretive analysis, vector loops, and can be 3, 6, 12, or 15 lead ECG3S, 12 lead interprones and resolution signal averaging of upgraded to provide software analysis options such as not reception of reception of Fecelling of ECG
QRS and P wave portions of the electrocardiogram. Transmission of ECG QRS and P wave portions of the electrocardiogram. "Annomes and is optional.
The MAC 5000 is intended to be used under the direct supervision of a licensed The MAC 5000 is intended to be used ander the Group Curcer of Collection of the
Prescription Use_X (Per 21 CFR 801.109 Subpart D) OR
Over-The-Counter Use_ (21 CFR 801 Subpart C)
(Please DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Neil R.P. Dgbr
(Division Sign-Off)
fo BSZ
Division of Cardiovascular Dev
510(k) Number K042177